Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Broker written in white with a man drawing a yellow underline.

Image source: Getty Images

Life360 Inc (ASX: 360)

According to a note out of Bell Potter, its analysts have retained their buy rating on this location technology company's shares with an improved price target of $20.50. This follows the release of a second quarter update that was comfortably ahead of expectations in respect to earnings. In addition, it notes that the key metrics of total paying circles, AMR, and ARPPC were also ahead of its forecasts, with the highlight being a record quarter for growth in paying circles of 132,000. And with the seasonally stronger third quarter to come, Bell Potter is feeling very positive about its outlook. The Life360 share price is trading at $17.26 today.

Light & Wonder Inc (ASX: LNW)

A note out of Morgans reveals that its analysts have retained their add rating and $180.00 price target on this gaming developer's shares. Morgans notes that Light & Wonder continued its strong momentum in the second quarter, delivering its 13th consecutive quarter of double-digit revenue growth. A key driver of this was the core land-based gaming division. It outperformed with both global outright sales and North American (NA) gaming operations delivering strong results thanks largely to the success of Dragon Train. Another positive for Morgans was its cash generation, which remained strong. The Light & Wonder share price is fetching $155.74 this afternoon.

QBE Insurance Group Ltd (ASX: QBE)

Another note out of Morgans reveals that its analysts have retained their add rating on this insurance giant's shares with a trimmed price target of $18.73. Morgans notes that QBE delivered a first half result that was largely in line with expectations. And while it was a touch disappointed with its dividend (which fell well short of consensus estimates) and its lowered guidance for the full year, it saw enough to remain positive. Particularly given that the performance of QBE's North American business improved during the half. As a result, it thinks investors should be snapping up shares at current levels. The QBE share price is trading at $16.26 on Monday.

Motley Fool contributor James Mickleboro has positions in Life360. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and Light & Wonder. The Motley Fool Australia has recommended Light & Wonder. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Why the Paladin Energy share price "doesn't make sense"

This uranium stock could be set for a major re-rating.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »

Man using his device in an airport.
Broker Notes

This high-quality ASX 200 share could rise 60%

A leading broker expects a good yield and major upside from this stock.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Broker Notes

Trading near 12-month lows, this ASX retailer could be set for a 54% gain

This baby goods retailer still has ample room to grow.

Read more »

three young children weariing business suits, helmets and old fashioned aviator goggles wear aeroplane wings on their backs and jump with one arm outstretched into the air in an arid, sandy landscape.
Broker Notes

5 ASX 200 stocks analysts have upgraded this week

Brokers have increased their ratings on PLS Group, Mineral Resources, Ampol, and other stocks. 

Read more »